$PFE Cashflow Statement | Understand Stock

$PFE

$29.79 -$0.24 (0.8%) Close

$PFE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating Activities
Net income before allocation to noncontrolling interests
Discontinued operations––net of tax
Net income from continuing operations before allocation to noncontrolling interests
Adjustments to reconcile net income from continuing operations before allocation to noncontrolling interests to net cash provided by/(used in) operating activities:
Depreciation and amortization
Asset write-offs and impairments
TCJA impact
Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed
Deferred taxes
Share-based compensation expense
Benefit plan contributions in excess of expense/income
Inventory write-offs and related charges associated with COVID-19 products
Other adjustments, net
Other changes in assets and liabilities, net of acquisitions and divestitures:
Trade accounts receivable
Inventories
Other assets
Trade accounts payable
Other liabilities
Other tax accounts, net

Net cash provided by/(used in) operating activities from continuing operations
Net cash provided by/(used in) operating activities from discontinued operations
Net cash provided by/(used in) operating activities
Investing Activities
Purchases of property, plant and equipment
Purchases of short-term investments
Proceeds from redemptions/sales of short-term investments
Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less
Purchases of long-term investments
Proceeds from redemptions/sales of long-term investments
Proceeds from partial sales of investment in Haleon
Acquisitions of businesses, net of cash acquired
Dividend received from the Consumer Healthcare JV
Other investing activities, net
Net cash provided by/(used in) investing activities from continuing operations
Net cash provided by/(used in) investing activities from discontinued operations
Net cash provided by/(used in) investing activities
Financing Activities
Proceeds from short-term borrowings
Payments on short-term borrowings
Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less
Proceeds from issuance of long-term debt
Payments on long-term debt
Purchases of common stock
Cash dividends paid
Other financing activities, net
Net cash provided by/(used in) financing activities from discontinued operations
Net cash provided by/(used in) financing activities

Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period
Cash and cash equivalents and restricted cash and cash equivalents, at end of period
Supplemental Cash Flow Information
Cash paid/(received) during the period for:
Income taxes
Interest paid
Interest rate hedges
Non-cash transaction:
Right-of-use assets obtained in exchange for lease liabilities
Equity investment in exchange for Pfizer's assets

Comments